Therapeutic Advances in Infectious Disease (Aug 2020)

Cutaneous Hyperpigmentation Secondary to High-Dose Tigecycline: A Case Report

  • Muhannad A. Alsemari,
  • Hakeam A. Hakeam,
  • Hussain Alsalman,
  • Tarek Amin

DOI
https://doi.org/10.1177/2049936120952605
Journal volume & issue
Vol. 7

Abstract

Read online

High-dose tigecycline therapy is gaining wide acceptance in treating infections caused by multidrug-resistant bacteria. There are no reports of cutaneous hyperpigmentation with the use of high-dose tigecycline. Here we report a case of a woman who developed reversible cutaneous hyperpigmentation within 48 h of receiving high-dose tigecycline.